Ohio Adult-Use Cannabis Sales Hit $1.5B Since 2024 Launch
The state's adult-use program has generated $55 million in excise tax revenue for host communities in under two years.

Detailed image of cannabis buds spilling from a glass jar, highlighting the green texture.
Revenue Trajectory Outpaces Initial State Projections
Ohio's adult-use cannabis program crossed the $1.5 billion sales threshold in its 24th month of operation, marking one of the fastest ramps in Midwest adult-use markets. The state Department of Commerce reported the milestone in its July 2026 update, released August 18. Michigan took 28 months to reach the same cumulative sales figure after its 2019 launch. Illinois needed 22 months following its January 2020 start.
The $55 million in excise tax collections flows directly to municipalities that opted in to host dispensaries under Ohio's local-control framework. That figure represents the 10 percent adult-use excise levy applied at point of sale, separate from the state's standard sales tax. Communities that passed local ordinances blocking dispensaries receive no share of the revenue.
The $6.54 per-gram average price reflects a 31 percent decline from the $9.50 average recorded in the program's first full month, September 2024. Price compression has accelerated as the state's dual-use license structure allowed existing medical operators to immediately serve adult-use customers without buildout delays.
Dual-Use License Model Drives Supply Density
Ohio authorized all 130 operational medical dispensaries to begin adult-use sales on day one, creating immediate statewide access that compressed wholesale and retail pricing faster than single-license states. The Division of Cannabis Control issued no new adult-use-only retail licenses in the program's first 18 months. It prioritized medical operators that had been active since the state's 2019 medical launch.
That dual-license approach contrasts sharply with New York's segmented rollout, where the Office of Cannabis Management issued Conditional Adult-Use Retail Dispensary licenses to new entrants before allowing medical operators to convert. Ohio's model front-loaded supply. The state avoided the inventory shortages and $18-per-gram pricing that plagued New York's first year.
Ohio began accepting applications for standalone adult-use retail licenses in March 2026, with the first approvals expected by October 2026. The Division of Cannabis Control hasn't disclosed how many applications it received or how many new licenses it intends to issue in the next allocation round.
What Comes Next for Ohio's Market Maturation
The next inflection point for Ohio's adult-use program is the October 2026 standalone license awards, which will test whether the state can absorb additional retail capacity without triggering a Michigan-style price collapse. Michigan's per-gram average fell below $3.50 in mid-2023 after the state approved more than 500 adult-use retailers, forcing wholesale flower prices down to $600 per pound and pushing smaller cultivators into distress.
Ohio's current retail density sits at roughly one dispensary per 90,000 residents. Michigan operates at one per 20,000. If the Division of Cannabis Control issues 50 new standalone licenses in the October round, the state would still maintain a more conservative retail footprint than Illinois, which operates at one dispensary per 65,000 residents.
For full context on Ohio's regulatory framework and market structure, see the CannIntel topic hub on Ohio's adult-use program.
The Division of Cannabis Control hasn't announced the timing of its next data release. Monthly updates typically lag by 30 to 45 days, meaning August 2026 sales figures will likely be published in late September or early October.
For complete background, history, and our ongoing coverage of this story:
Open the CannIntel topic hub →Frequently asked questions
How much has Ohio collected in adult-use cannabis excise taxes?
Ohio has collected $55 million in excise tax revenue from adult-use cannabis sales since the program launched in August 2024. The state applies a 10 percent excise tax at point of sale, and revenue flows directly to municipalities that host dispensaries.
What is the average price per gram of cannabis in Ohio?
The statewide average price per gram in Ohio is $6.54 as of July 2026, according to the Department of Commerce. That represents a 31 percent decline from the $9.50 average recorded in September 2024, the program's first full month.
How many cannabis dispensaries operate in Ohio?
Ohio has 130 operational dispensaries serving both medical and adult-use customers. All were originally licensed as medical-only facilities and received authorization to serve adult-use customers when the program launched in August 2024.
When will Ohio issue new adult-use cannabis licenses?
The Division of Cannabis Control began accepting applications for standalone adult-use retail licenses in March 2026, with the first approvals expected by October 2026. The agency has not disclosed how many new licenses it will issue.
How does Ohio's cannabis market compare to Michigan and Illinois?
Ohio reached $1.5 billion in cumulative sales in 24 months, faster than Michigan (28 months) and comparable to Illinois (22 months). Ohio maintains lower retail density than Michigan, with one dispensary per 90,000 residents versus Michigan's one per 20,000.
Sources
The cannabis newsletter you forward to your team.
Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.
No spam. Unsubscribe with one click. 21+ only.
Related from Business

Organigram enters fight for Aurora as Curaleaf bid clock runs
British American Tobacco's stake in Organigram could put the tobacco giant at the center of the Aurora contest before Curaleaf's offer expires Dec. 4.

Tilray Medical Wins Approval for In-House EU-GMP Cannabis Testing
Tilray Medical can now run EU-GMP quality testing in-house, a move that could shift lab costs and batch-release timing, though key details remain undisclosed.

Canopy Growth Secures EU-GMP Certification at Smiths Falls
Canopy Growth's Smiths Falls site is now certified for softgel manufacturing and primary packaging of softgels, oral liquids and dried flower, extending its EU-GMP supply chain.
More from the newsroom

DEA Accepts New Report in Rescheduling Hearing; Foes Seek Discovery
DEA does not object to a new report entering the marijuana rescheduling record, while opponents ask for added testimony and document discovery.

Puerto Rico Rolls Back Medical Cannabis Workplace Protections
High Times Magazine reports Puerto Rico has narrowed employment protections for medical cannabis patients, raising questions about which workers lose coverage and which keep it.

L.A. Cannabis Industry Rallies Behind Nithya Raman, Substack Reports
A High Adam post says Los Angeles operators are energizing around Councilmember Nithya Raman, but the platform details behind the 'actual plan' remain unverified.